DE102011118022B4 - Antikörper gegen das Prostata-spezifische Stammzellenantigen und dessen Verwendung - Google Patents
Antikörper gegen das Prostata-spezifische Stammzellenantigen und dessen Verwendung Download PDFInfo
- Publication number
- DE102011118022B4 DE102011118022B4 DE102011118022.6A DE102011118022A DE102011118022B4 DE 102011118022 B4 DE102011118022 B4 DE 102011118022B4 DE 102011118022 A DE102011118022 A DE 102011118022A DE 102011118022 B4 DE102011118022 B4 DE 102011118022B4
- Authority
- DE
- Germany
- Prior art keywords
- antibody
- seq
- psca
- antibodies
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2809—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gynecology & Obstetrics (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Pregnancy & Childbirth (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (23)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102011118022.6A DE102011118022B4 (de) | 2011-06-30 | 2011-06-30 | Antikörper gegen das Prostata-spezifische Stammzellenantigen und dessen Verwendung |
| HUE12729996A HUE042008T2 (hu) | 2011-06-30 | 2012-06-29 | Prosztataspecifikus õssejt antigén elleni antitestek és alkalmazásuk |
| US14/129,933 US9200078B2 (en) | 2011-06-30 | 2012-06-29 | Antibodies against prostate-specific stem cell antigen and use thereof |
| RS20190218A RS58448B1 (sr) | 2011-06-30 | 2012-06-29 | Antitela protiv antigena matičnih ćelija specifičan za prostatu i njihova upotreba |
| JP2014517736A JP2014528696A (ja) | 2011-06-30 | 2012-06-29 | 前立腺特異幹細胞抗原に対する抗体およびその使用 |
| HRP20190289TT HRP20190289T1 (hr) | 2011-06-30 | 2012-06-29 | Protutijela protiv antigena specifičnog za matične stanice prostate i njihova upotreba |
| SM20190085T SMT201900085T1 (it) | 2011-06-30 | 2012-06-29 | Anticorpi contro l'antigene delle cellule staminali prostatiche e suo uso |
| SI201231523T SI2726507T1 (sl) | 2011-06-30 | 2012-06-29 | Protitelesa proti antigenu prostatno specifičnih matičnih celic in njihova uporaba |
| DK12729996.4T DK2726507T3 (en) | 2011-06-30 | 2012-06-29 | ANTIBODY AGAINST THE PROSTATE-SPECIFIC STEM CELL ANTIGEN AND ITS USE |
| EP12729996.4A EP2726507B1 (de) | 2011-06-30 | 2012-06-29 | Antikörper gegen das prostata-spezifische stammzellantigen und dessen verwendung |
| TR2019/01991T TR201901991T4 (tr) | 2011-06-30 | 2012-06-29 | Prostat spesifik kök hücre antijenine karşı antikor ve bunun kullanımı. |
| EP18207370.0A EP3505536B1 (de) | 2011-06-30 | 2012-06-29 | Antikörper gegen das prostata-spezifische stammzellantigen und dessen verwendung |
| LTEP12729996.4T LT2726507T (lt) | 2011-06-30 | 2012-06-29 | Antikūnai, atpažįstantys prostatai specifinį kamieninių ląstelių antigeną, ir jų panaudojimas |
| AU2012277784A AU2012277784B2 (en) | 2011-06-30 | 2012-06-29 | Antibodies against prostate-specific stem cell antigen and use thereof |
| ES12729996T ES2711978T3 (es) | 2011-06-30 | 2012-06-29 | Anticuerpos contra el antígeno de células madre específico de la próstata y su uso |
| PT12729996T PT2726507T (pt) | 2011-06-30 | 2012-06-29 | Anticorpos contra antigéneos celulares especificos da próstata e uso dos mesmos |
| PL12729996T PL2726507T3 (pl) | 2011-06-30 | 2012-06-29 | Przeciwciała przeciwko antygenowi komórek macierzystych swoistemu dla gruczołu krokowego i ich zastosowanie |
| ES18207370T ES2989975T3 (es) | 2011-06-30 | 2012-06-29 | Anticuerpos contra el antígeno de células madre específico de la próstata y su uso |
| PCT/EP2012/062716 WO2013001065A1 (de) | 2011-06-30 | 2012-06-29 | Antikörper gegen das prostata-spezifische stammzellantigen und dessen verwendung |
| JP2017002983A JP6549622B2 (ja) | 2011-06-30 | 2017-01-12 | 前立腺特異幹細胞抗原に対する抗体およびその使用 |
| CY20191100176T CY1121249T1 (el) | 2011-06-30 | 2019-02-11 | Αντισωμα εναντι του ειδικου προστατικου αντιγονου βλαστικου κυτταρου και χρησεις αυτου |
| JP2019117977A JP6886491B2 (ja) | 2011-06-30 | 2019-06-26 | 前立腺特異幹細胞抗原に対する抗体およびその使用 |
| JP2021081553A JP7341185B2 (ja) | 2011-06-30 | 2021-05-13 | 前立腺特異幹細胞抗原に対する抗体およびその使用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102011118022.6A DE102011118022B4 (de) | 2011-06-30 | 2011-06-30 | Antikörper gegen das Prostata-spezifische Stammzellenantigen und dessen Verwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE102011118022A1 DE102011118022A1 (de) | 2013-01-03 |
| DE102011118022B4 true DE102011118022B4 (de) | 2018-01-18 |
Family
ID=46384405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE102011118022.6A Expired - Fee Related DE102011118022B4 (de) | 2011-06-30 | 2011-06-30 | Antikörper gegen das Prostata-spezifische Stammzellenantigen und dessen Verwendung |
Country Status (18)
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102011118022B4 (de) * | 2011-06-30 | 2018-01-18 | Gemoab Monoclonals Gmbh | Antikörper gegen das Prostata-spezifische Stammzellenantigen und dessen Verwendung |
| ES2688035T3 (es) | 2014-08-29 | 2018-10-30 | Gemoab Monoclonals Gmbh | Receptor de antígeno universal que expresa células inmunes para direccionamiento de antígenos múltiples diversos, procedimiento para fabricación del mismo y utilización del mismo para tratamiento de cáncer, infecciones y enfermedades autoinmunes |
| CN110944651A (zh) | 2017-02-08 | 2020-03-31 | 蜻蜓疗法股份有限公司 | 用于自然杀伤细胞激活的多特异性结合蛋白及其治疗癌症的治疗性用途 |
| EP4273258A3 (en) | 2017-02-20 | 2024-01-17 | Dragonfly Therapeutics, Inc. | Proteins binding her2, nkg2d and cd16 |
| WO2019066093A1 (ko) * | 2017-09-26 | 2019-04-04 | 주식회사 와이바이오로직스 | Scf 특이적 항체 |
| CA3090244A1 (en) | 2018-02-08 | 2019-08-15 | Dragonfly Therapeutics, Inc. | Antibody variable domains targeting the nkg2d receptor |
| MX2020008333A (es) | 2018-02-08 | 2020-09-21 | Dragonfly Therapeutics Inc | Terapia de combinacion del cancer que incluye proteinas de union multiespecificas que activan a las celulas asesinas naturales. |
| CN112119093A (zh) | 2018-02-20 | 2020-12-22 | 蜻蜓治疗公司 | 结合cd33、nkg2d和cd16的多特异性结合蛋白和使用方法 |
| CA3108427A1 (en) | 2018-08-08 | 2020-02-13 | Dragonfly Therapeutics, Inc. | Multi-specific binding proteins that bind bcma, nkg2d and cd16, and methods of use |
| CN113164570B (zh) | 2018-08-08 | 2024-05-14 | 蜻蜓疗法股份有限公司 | 结合nkg2d、cd16和肿瘤相关抗原的蛋白质 |
| EA202091888A1 (ru) | 2018-08-08 | 2020-10-23 | Драгонфлай Терапьютикс, Инк. | Вариабельные домены антител, нацеленные на рецептор nkg2d |
| AU2021268340A1 (en) | 2020-05-06 | 2022-12-08 | Dragonfly Therapeutics, Inc. | Proteins binding NKG2D, CD16 and CLEC12A |
| AU2021276327A1 (en) * | 2020-05-19 | 2022-12-01 | City Of Hope | Engineered anti-prostate stem cell antigen fusion proteins and uses thereof |
| EP4301774A4 (en) | 2021-03-03 | 2025-08-13 | Dragonfly Therapeutics Inc | METHODS OF TREATING CANCER USING MULTI-SPECIFIC BINDING PROTEINS THAT BIND TO NKG2D, CD16, AND A TUMOR-ASSOCIATED ANTIGEN |
| WO2024233662A2 (en) * | 2023-05-09 | 2024-11-14 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Molecules that bind to psca polypeptides |
| US20250302763A1 (en) | 2024-02-22 | 2025-10-02 | Capstan Therapeutics, Inc. | Immune engineering amplification |
| CN121673412A (zh) * | 2024-09-12 | 2026-03-17 | 上海医药工业研究院有限公司 | 一种靶向psca的纳米抗体及其应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009032949A2 (en) * | 2007-09-04 | 2009-03-12 | The Regents Of The University Of California | High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection |
| US20110142811A1 (en) * | 2009-12-16 | 2011-06-16 | Deutsches Krebsforschungszentrum | Measles virus for the elimination of unwanted cell populations |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4404381B2 (ja) * | 1997-03-10 | 2010-01-27 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Psca:前立腺幹細胞抗原 |
| US6541212B2 (en) | 1997-03-10 | 2003-04-01 | The Regents Of The University Of California | Methods for detecting prostate stem cell antigen protein |
| KR100490077B1 (ko) * | 1999-10-29 | 2005-05-17 | 제넨테크, 인크. | 항-전립선 줄기세포 항원 (psca) 항체 조성물 및 그의사용 방법 |
| US8076459B2 (en) * | 2003-10-16 | 2011-12-13 | Micromet Ag | Multispecfic deimmunized CD3-binders |
| RU2381234C2 (ru) * | 2004-05-28 | 2010-02-10 | Эдженсис, Инк. | Антитела и родственные молекулы, связывающиеся с белками psca |
| KR101837053B1 (ko) * | 2008-10-01 | 2018-03-12 | 암젠 리서치 (뮌헨) 게엠베하 | 종간 특이적 PSCAxCD3, CD19xCD3, c-METxCD3, 엔도시알린xCD3, EpCAMxCD3, IGF-1RxCD3 또는 FAPαxCD3 이중특이적 단일쇄 항체 |
| DE102011118022B4 (de) * | 2011-06-30 | 2018-01-18 | Gemoab Monoclonals Gmbh | Antikörper gegen das Prostata-spezifische Stammzellenantigen und dessen Verwendung |
-
2011
- 2011-06-30 DE DE102011118022.6A patent/DE102011118022B4/de not_active Expired - Fee Related
-
2012
- 2012-06-29 ES ES18207370T patent/ES2989975T3/es active Active
- 2012-06-29 EP EP18207370.0A patent/EP3505536B1/de active Active
- 2012-06-29 HR HRP20190289TT patent/HRP20190289T1/hr unknown
- 2012-06-29 HU HUE12729996A patent/HUE042008T2/hu unknown
- 2012-06-29 EP EP12729996.4A patent/EP2726507B1/de active Active
- 2012-06-29 AU AU2012277784A patent/AU2012277784B2/en not_active Ceased
- 2012-06-29 ES ES12729996T patent/ES2711978T3/es active Active
- 2012-06-29 JP JP2014517736A patent/JP2014528696A/ja active Pending
- 2012-06-29 SM SM20190085T patent/SMT201900085T1/it unknown
- 2012-06-29 US US14/129,933 patent/US9200078B2/en active Active
- 2012-06-29 WO PCT/EP2012/062716 patent/WO2013001065A1/de not_active Ceased
- 2012-06-29 PL PL12729996T patent/PL2726507T3/pl unknown
- 2012-06-29 DK DK12729996.4T patent/DK2726507T3/en active
- 2012-06-29 SI SI201231523T patent/SI2726507T1/sl unknown
- 2012-06-29 TR TR2019/01991T patent/TR201901991T4/tr unknown
- 2012-06-29 RS RS20190218A patent/RS58448B1/sr unknown
- 2012-06-29 LT LTEP12729996.4T patent/LT2726507T/lt unknown
- 2012-06-29 PT PT12729996T patent/PT2726507T/pt unknown
-
2017
- 2017-01-12 JP JP2017002983A patent/JP6549622B2/ja not_active Expired - Fee Related
-
2019
- 2019-02-11 CY CY20191100176T patent/CY1121249T1/el unknown
- 2019-06-26 JP JP2019117977A patent/JP6886491B2/ja active Active
-
2021
- 2021-05-13 JP JP2021081553A patent/JP7341185B2/ja active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009032949A2 (en) * | 2007-09-04 | 2009-03-12 | The Regents Of The University Of California | High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection |
| US20110142811A1 (en) * | 2009-12-16 | 2011-06-16 | Deutsches Krebsforschungszentrum | Measles virus for the elimination of unwanted cell populations |
Non-Patent Citations (1)
| Title |
|---|
| Feldmann, A., Stamova, S., Bippes, C.C. et al., The Prostate, 71: 998-1011; 2011. * |
Also Published As
| Publication number | Publication date |
|---|---|
| HUE042008T2 (hu) | 2019-06-28 |
| DK2726507T3 (en) | 2019-03-11 |
| HRP20190289T1 (hr) | 2019-05-03 |
| TR201901991T4 (tr) | 2019-03-21 |
| LT2726507T (lt) | 2019-04-10 |
| SI2726507T1 (sl) | 2019-05-31 |
| JP2017104113A (ja) | 2017-06-15 |
| JP2014528696A (ja) | 2014-10-30 |
| RS58448B1 (sr) | 2019-04-30 |
| EP2726507B1 (de) | 2018-11-21 |
| WO2013001065A1 (de) | 2013-01-03 |
| ES2989975T3 (es) | 2024-11-28 |
| JP2019193652A (ja) | 2019-11-07 |
| JP6549622B2 (ja) | 2019-07-24 |
| JP7341185B2 (ja) | 2023-09-08 |
| PL2726507T3 (pl) | 2019-06-28 |
| CY1121249T1 (el) | 2020-05-29 |
| AU2012277784B2 (en) | 2015-08-20 |
| EP2726507A1 (de) | 2014-05-07 |
| EP3505536B1 (de) | 2024-08-07 |
| ES2711978T3 (es) | 2019-05-08 |
| EP3505536C0 (de) | 2024-08-07 |
| DE102011118022A1 (de) | 2013-01-03 |
| AU2012277784A1 (en) | 2014-02-06 |
| JP6886491B2 (ja) | 2021-06-16 |
| US9200078B2 (en) | 2015-12-01 |
| SMT201900085T1 (it) | 2019-05-10 |
| PT2726507T (pt) | 2019-02-26 |
| US20140134155A1 (en) | 2014-05-15 |
| JP2021121201A (ja) | 2021-08-26 |
| EP3505536A1 (de) | 2019-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2726507B1 (de) | Antikörper gegen das prostata-spezifische stammzellantigen und dessen verwendung | |
| JP7605912B2 (ja) | Gprc5dキメラ抗原受容体及びそれを発現する細胞 | |
| EP2480574B1 (de) | Anti-cd33 antikörper und ihre anwendung zum immunotargeting bei der behandlung von cd33-assoziierten erkrankungen | |
| DE60127143T2 (de) | Bispezifische Antikörper gegen CD19 und CD16 und deren Verwendung | |
| EP2600889B1 (de) | Anti-la antikörper und ihre anwendung zum immunotargeting | |
| US20220144928A1 (en) | Antibody-based therapy of transthyretin (ttr) amyloidosis and human-derived antibodies therefor | |
| KR102749049B1 (ko) | 분자를 표적화하기 위한 항원 결합 구조체 | |
| DE69909459T2 (de) | Cd19xcd3 spezifische polypeptide und deren verwendung | |
| US20050176934A1 (en) | Antibody combination useful for tumor therapy | |
| JP2024522349A (ja) | C-x-cモチーフケモカイン受容体6(cxcr6)結合分子及びその使用方法 | |
| DE102010039019B4 (de) | Antikörper gegen 6-sulfo LacNAc positive humane dendritische Zellen und deren Verwendung | |
| DE19744531A1 (de) | Bindemoleküle gegen Rezeptor-Ligand-Komplexe | |
| HK1197419B (en) | Antibodies against prostate-specific stem cell antigen and use thereof | |
| HK1197419A (en) | Antibodies against prostate-specific stem cell antigen and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R012 | Request for examination validly filed | ||
| R123 | Application deemed withdrawn due to non-payment of filing fee | ||
| R409 | Internal rectification of the legal status completed | ||
| R409 | Internal rectification of the legal status completed | ||
| R409 | Internal rectification of the legal status completed | ||
| R082 | Change of representative |
Representative=s name: KAILUWEIT & UHLEMANN, PATENTANWAELTE, DE |
|
| R081 | Change of applicant/patentee |
Owner name: GEMOAB MONOCLONALS GMBH, DE Free format text: FORMER OWNER: TECHNISCHE UNIVERSITAET DRESDEN, 01069 DRESDEN, DE Effective date: 20140318 |
|
| R082 | Change of representative |
Representative=s name: KAILUWEIT & UHLEMANN, PATENTANWAELTE, DE Effective date: 20140318 Representative=s name: KAILUWEIT & UHLEMANN PATENTANWAELTE PARTNERSCH, DE Effective date: 20140318 |
|
| R016 | Response to examination communication | ||
| R018 | Grant decision by examination section/examining division | ||
| R020 | Patent grant now final | ||
| R119 | Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee |